Oak Associates LTD Biogen Inc. Transaction History

Oak Associates LTD

$1.51 Billion
Q2 2024

A detailed history of Oak Associates LTD transactions in Biogen Inc. stock. As of the latest transaction made, Oak Associates LTD holds 6,190 shares of BIIB stock, worth $1.08 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares

6,190

Previous 6,190 -0.0%

Holding current value

$1.08 Million

Previous $1.33 Million 7.5%

% of portfolio

0.1%

Previous 0.09%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$222.59 - $267.94 $55,647 - $66,985	-250 Reduced 3.88%	6,190 $1.6 Million
Q3 2023 Nov 13, 2023	BUY	$253.3 - $285.89 $63,325 - $71,472	250 Added 4.04%	6,440 $1.66 Million
Q3 2022 Nov 09, 2022	BUY	$194.69 - $268.46 $162,566 - $224,164	835 Added 15.59%	6,190 $1.65 Million
Q1 2022 May 12, 2022	SELL	$193.77 - $244.14 $125,950 - $158,691	-650 Reduced 10.82%	5,355 $1.13 Million
Q4 2021 Feb 10, 2022	SELL	$223.92 - $287.77 $67,176 - $86,331	-300 Reduced 4.76%	6,005 $1.44 Million
Q2 2021 Aug 09, 2021	SELL	$259.0 - $414.71 $747,733 - $1.2 Million	-2,887 Reduced 31.41%	6,305 $2.18 Million
Q1 2021 May 13, 2021	SELL	$242.95 - $284.63 $1.96 Million - $2.3 Million	-8,081 Reduced 46.78%	9,192 $2.57 Million
Q3 2020 Nov 13, 2020	SELL	$264.77 - $305.71 $807,548 - $932,415	-3,050 Reduced 15.01%	17,273 $4.9 Million
Q2 2020 Aug 11, 2020	BUY	$258.66 - $342.55 $3,879 - $5,138	15 Added 0.07%	20,323 $5.44 Million
Q1 2020 May 15, 2020	SELL	$268.85 - $341.04 $454,356 - $576,357	-1,690 Reduced 7.68%	20,308 $6.43 Million
Q4 2019 Feb 13, 2020	SELL	$220.06 - $304.07 $473,129 - $653,750	-2,150 Reduced 8.9%	21,998 $6.53 Million
Q3 2019 Nov 12, 2019	BUY	$217.44 - $243.88 $53,272 - $59,750	245 Added 1.02%	24,148 $5.62 Million
Q1 2019 May 09, 2019	SELL	$216.71 - $338.96 $3,250 - $5,084	-15 Reduced 0.06%	23,903 $5.65 Million
Q4 2018 Feb 07, 2019	BUY	$278.5 - $352.75 $2.35 Million - $2.97 Million	8,433 Added 54.46%	23,918 $7.2 Million
Q3 2018 Nov 13, 2018	BUY	$293.51 - $383.83 $102,728 - $134,340	350 Added 2.31%	15,485 $5.47 Million
Q2 2018 Aug 14, 2018	BUY	$257.52 - $306.91 $93,994 - $112,022	365 Added 2.47%	15,135 $4.39 Million
Q4 2017 Feb 08, 2018	SELL	$307.64 - $344.58 $83,062 - $93,036	-270 Reduced 1.8%	14,770 $4.71 Million
Q2 2017 Aug 18, 2017	BUY	N/A	15,040	15,040 $4.08 Million

Others Institutions Holding BIIB

# of Institutions

1,022

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Oak Associates LTD , based on Form 13F filings with the SEC.

News

Stay updated on Oak Associates LTD with notifications on news.

Account

Oak Associates LTD Biogen Inc. Transaction History